Bin Qiu

机构：Weifang Medical University, Hunan Normal University, Chinese Academy of Medical Sciences & Peking Union Medical College, Changsha Normal University, National Cancer Center, Shandong Academy of Agricultural Sciences, National Clinical Research · ORCID：0000-0001-6466-3979

发表论文 113 篇 · 总被引 4158 次 · h-index 28

代表论文

• TIGIT / CD47 dual high expression predicts prognosis and is associated with immunotherapy response in lung squamous cell carcinoma (2022 · Thoracic Cancer · 被引 15)
• Molecular risk factors for locoregional recurrence in resected non‐small cell lung cancer (2023 · Cancer Medicine · 被引 10)
• Risk of treatment-related toxicity from EGFR tyrosine kinase inhibitors: a systematic review and network meta-analysis of randomized clinical trials in EGFR-mutant non-small cell lung cancer (2024 · Journal of Thoracic Disease · 被引 9)
• The presence of micropapillary and/or solid subtypes is an independent prognostic factor for patients undergoing curative resection for stage I lung adenocarcinoma with ground-glass opacity (2024 · Translational Lung Cancer Research · 被引 9)
• RETRACTED: Effect of thoracoscopic and thoracotomy on postoperative wound complications in patients with lung cancer: A meta‐analysis (2023 · International Wound Journal · 被引 9)
• Five-year follow-up of neoadjuvant PD-1 inhibitor (sintilimab) in non-small cell lung cancer (2024 · Journal for ImmunoTherapy of Cancer · 被引 8)